Cardinal Health, Inc.

NYSE:CAH

Market Cap

USD 38.52 B

Share Price

USD 161.41

Avg Daily Volume

2,509,353

Change (1 day)

0.55%

Change (1 year)

60.43%

Change (YTD)

36.48%

Cardinal Health, Inc. Price to Book Ratio (P/B) on June 13, 2025: -12.40

Cardinal Health, Inc. Price to Book Ratio (P/B) is -12.40 on June 13, 2025, a 66.87% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Cardinal Health, Inc. 52-week low Price to Book Ratio (P/B) is -6.74 on June 13, 2025, which is 45.67% above the current Price to Book Ratio (P/B).
  • Cardinal Health, Inc. 52-week low Price to Book Ratio (P/B) is -12.40 on June 13, 2025, which is 0.00% below the current Price to Book Ratio (P/B).
  • Cardinal Health, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is -9.07.
Key data
Date Price to Book Ratio (P/B) Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield
Market news
Loading...
NYSE: CAH

Cardinal Health, Inc.

CEO Mr. Jason M. Hollar
IPO Date Aug. 4, 1983
Location United States
Headquarters 7000 Cardinal Place
Employees 47,922
Sector 🏥 Health Care
Industries
Description

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Similar companies

HSIC

Henry Schein, Inc.

USD 70.19

-1.25%

MCK

McKesson Corporation

USD 728.20

-0.36%

EDAP

EDAP TMS S.A.

USD 1.71

-3.39%

ZYXI

Zynex, Inc.

USD 2.10

1.45%

OMI

Owens & Minor, Inc.

USD 7.79

-2.26%

StockViz Staff

June 16, 2025

Any question? Send us an email